You are currently viewing our desktop site, do you want to download our app instead?
Moneyweb Android App Moneyweb iOS App Moneyweb Mobile Web App

NEW SENS search and JSE share prices

More about the app

J&J agrees to supply up to 400m vaccines to African Union

Delivering a boost to a continent trailing most of the world in the race to inoculate against the disease.
Image: Stephen Zenner/Bloomberg

Johnson & Johnson agreed to supply as many as 400 million Covid-19 vaccines to the African Union through the end of next year, delivering a boost to a continent trailing most of the world in the race to inoculate against the disease.

The US drugmaker can make available as many as 220 million doses of its single-shot candidate to the AU’s 55 member states starting in the third quarter of 2021, according to a statement on Monday. A further 180 million could then be delivered the following year. The pact follows agreements with AstraZeneca Plc, Pfizer Inc. and the makers of Russia’s Sputnik vaccine.

Moneyweb Insider INSIDERGOLD

Subscribe for full access to all our share and unit trust data tools, our award-winning articles, and support quality journalism in the process.

Choose an option:

R63 per month
R630 per year SAVE R126

You will be redirected to a checkout page.
To view all features and options, click here.

A monthly subscription is charged pro rata, based on the day of purchase. This is non-refundable and includes a R5 once-off sign-up fee.
A yearly subscription is refundable within 14 days of purchase and includes a 365-day membership.

Click here for more information.

“No one is safe until everyone is safe, and we have been committed to equitable, global access to new Covid-19 vaccines,” J&J Chief Executive Officer Alex Gorsky said in the statement.

While the J&J vaccine has started to receive approval in some countries around the world, the delivery commitment to the AU will depend on regulatory backing from member nations. The dose’s requirement for just a single shot is seen as beneficial for Africa, where distribution is likely to present a major challenge.

South Africa has already started administering the vaccine to health workers as part of a medical trial, and J&J agreed last year that Aspen Pharmacare Holdings Ltd. can manufacture doses in the country.

J&J in December signed a separate agreement to supply the global program known as Covax with as many as 500 million doses of its shot. The company said at the time that it expected to provide 100 million doses of its vaccine in 2021 as part of the initial accord with Gavi, the Vaccine Alliance, one of the partners in Covax.

© 2021 Bloomberg

COMMENTS   1

You must be signed in to comment.

SIGN IN SIGN UP

Sweet of J &J but they will supply the first world first. We will get the leftovers as the ANC were snoring again while thousands died in agony

End of comments.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR

Podcasts

INSIDER SUBSCRIPTIONS APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING PORTFOLIO TOOL CPD HUB

Follow us:

Search Articles: Advanced Search
Click a Company: